What is CPRX's Value Score?

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) has a StockPik Value Score of 79 out of 100 — a high score, indicating strong value characteristics across multiple metrics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is CPRX's Piotroski F-Score?

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) has a Piotroski F-Score of 4 out of 9 — a moderate score. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is CPRX trading below its Graham Number?

CPRX is currently trading above its Graham Number. The stock price of $31.45 exceeds the Graham Number of $18.52, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is CPRX's Graham Number?

CPRX's Graham Number is $18.52, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $31.45, CPRX is trading 70% above its Graham Number.

What is CPRX's Piotroski F-Score?

CPRX's Piotroski F-Score is 4 out of 9, indicating moderate financial health. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is CPRX (Catalyst Pharmaceuticals, Inc. - Common Stock) undervalued?

CPRX scores 79/100 on StockPik's Value Score, placing it in undervalued territory. The stock trades 70% above its Graham Number of $18.52.

What is CPRX's P/E ratio?

CPRX's trailing P/E ratio is 17.1x — a reasonable earnings multiple. The Healthcare sector average P/E is 25.5x. Compare against other Healthcare stocks in the StockPik screener.

What sector is Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) in?

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) is in the Healthcare sector, specifically in the Pharmaceutical Preparations industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX)

NASDAQ Mid Cap

Healthcare › Pharmaceutical Preparations

$31.45

Market Cap: $3.8B

Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — Jul 6, 2026

Investment Snapshot

Trading 70% above Graham Number — above intrinsic value estimate
Piotroski F-Score 4/9 — moderate financial health
Strong ROE of 22.3% with 38.5% net margin
Revenue growing at 20% annually

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $3.8 billion . Key value metrics: P/E ratio 17.1, P/B ratio 3.80, Piotroski F-Score 4 out of 9 (moderate financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

17.08

P/B Ratio

3.80

EPS

$1.84

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Current vs 5-Year Average

Based on 5 years of SEC filings

Net Margin

—

↑ +2.1pp avg —

Gross Margin

—

↑ +2.1pp avg —

Operating Margin

—

↑ +2.1pp avg —

Return on Equity

—

↑ +2.1pp avg —

Debt / Equity

—

↑ +2.1pp avg —

See How Margins & ROE Have Trended — Try PRO

Revenue & Net Income

Profit Margins

Track Gross, Operating & Net Margins — Try PRO

EPS & Free Cash Flow Per Share

See EPS & Free Cash Flow Trends — Try PRO

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Catalyst Pharmaceuticals, Inc. - Common Stock — Fundamental Analysis Summary

Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) is currently trading 70% above its Graham Number of $18.52, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 17.1x.

On financial health, CPRX shows a moderate Piotroski F-Score of 4/9, and strong return on equity of 22.3% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.16.

StockPik's composite Value Score for CPRX is 79/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

CPRX reports a high gross margin of 87.1% (sector average: 39.4%) and a strong operating margin of 46.0%.

CPRX shows revenue growing at 20% year-over-year, with earnings growing at 31%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
HCM	HUTCHMED (China) Limited - American Depositary Shares	$11.45	4.4	100
CGEN	Compugen Ltd. - Ordinary Shares	$2.28	6.1	100
GMAB	Genmab A/S - American Depositary Shares	$26.33	1.8	100
BDTX	Black Diamond Therapeutics, Inc. - Common Stock	$1.84	3.7	100
EMBC	Embecta Corp. - Common Stock	$3.29	1.8	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

CPRT — Copart, Inc. - Common Stock

CPS Technologies Corp. - Common Stock — CPSH